Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
10 BPC-157 has demonstrated significant angiogenic effects in various healing models
Typical Protocol: Commonly cited protocols use 1.5-1.6 mg subcutaneously two to three times per week (mirroring the Zadaxin regimen used in hepatitis trials), often run in 4 to 16 week cycles for general wellness use, with the original clinical trials using 1.6 mg twice weekly for 6 to 12 months
SeekPeptides members access protocol templates that include reconstitution scheduling, helping coordinate multiple peptides within comprehensive programs
Active Ingredient
Pediatric Dosing Recommended dosage for children may vary based on different medical conditions: For the initial treatment of pernicious anemia, the usual dose is 30-50mcg SC/IM, given every day for 2 weeks, followed by maintenance treatment
US$ 22.06
US$ 20.14
US$ 21.11
US$ 22.49
US$ 26.76
